Profile data is unavailable for this security.
About the company
Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.
- Revenue in EUR (TTM)9.84m
- Net income in EUR-14.13m
- Incorporated1999
- Employees134.00
- LocationCoDon AGWarthestrasse 21TELTOW 14513GermanyDEU
- Phone+49 332843460
- Fax+49 3 328434643
- Websitehttps://www.codon.de/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XP Chemistries AB | 56.70k | -686.76k | 355.16k | 2.00 | -- | 0.1618 | -- | 6.26 | -0.2846 | -0.2846 | 0.0213 | 0.275 | 0.023 | 0.2084 | 5.99 | 331,845.00 | -27.79 | -- | -29.36 | -- | 50.57 | -- | -1,211.24 | -- | 5.79 | -- | 0.00 | -- | -37.14 | -- | -1.55 | -- | -- | -- |
| European Institute of Science AB | 51.26k | -232.03k | 439.88k | 0.00 | -- | 1.28 | -- | 8.58 | -4.25 | -4.25 | 0.9397 | 2.98 | 0.1728 | 0.8479 | 8.63 | -- | -78.21 | -93.04 | -82.77 | -103.14 | 62.33 | 67.01 | -452.67 | -518.82 | 10.54 | -- | -- | -- | 13.69 | 8.54 | 0.4062 | -- | -- | -- |
| MediNavi AG | -100.00bn | -100.00bn | 483.25k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Bio Vitos Pharma AB | 254.92k | -1.10m | 528.47k | 1.00 | -- | 1.61 | 12.05 | 2.07 | -0.2547 | -0.2547 | 0.0533 | 0.1119 | 0.0989 | 0.00 | 5.38 | 2,983,990.00 | -42.63 | -31.11 | -44.50 | -32.92 | 100.00 | -- | -431.21 | -1,026.76 | 4.27 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
| Eurocine Vaccines AB | 427.00 | -1.29m | 563.97k | 3.00 | -- | -- | -- | 1,320.33 | -0.1472 | -0.1472 | 0.00005 | -0.0018 | 0.0007 | -- | 0.002 | -- | -199.76 | -83.17 | -323.19 | -97.89 | -199,780.00 | -- | -301,180.00 | -- | -- | -- | -- | -- | -- | -- | 8.95 | -- | -- | -- |
| CoDon AG | 9.84m | -14.13m | 604.32k | 134.00 | -- | 0.0912 | -- | 0.0614 | -0.5513 | -0.5513 | 0.4018 | 0.2468 | 0.5161 | 0.9864 | 10.10 | 73,432.84 | -74.08 | -41.86 | -86.85 | -48.53 | 94.10 | 91.39 | -143.53 | -139.57 | 0.8393 | -21.92 | 0.4887 | -- | 57.28 | 11.86 | 32.79 | -- | 24.07 | -- |
| Lipidor AB | 6.58k | -981.24k | 606.49k | -- | -- | -- | -- | 92.20 | -0.3964 | -0.3964 | 0.0027 | -0.3223 | 0.0084 | -- | 5.31 | -- | -124.54 | -59.41 | -- | -75.10 | -- | -- | -14,916.88 | -643.36 | -- | -- | -- | -- | 73.33 | -20.33 | 72.24 | -- | -- | -- |
| QuiaPEG Pharmaceuticals Holding AB | 0.00 | -1.41m | 614.80k | 8.00 | -- | 0.4719 | -- | -- | -3.51 | -3.51 | 0.00 | 0.2047 | 0.00 | -- | -- | -- | -50.53 | -95.67 | -100.54 | -207.86 | -- | 262.59 | -- | -5,002.50 | -- | -15.34 | 0.00 | -- | -- | -- | 17.75 | -- | 47.06 | -- |
| Stayble Therapeutics AB | 0.00 | -2.03m | 620.56k | 3.00 | -- | 0.44 | -- | -- | -0.9492 | -0.9492 | 0.00 | 0.5204 | 0.00 | -- | -- | 0.00 | -116.21 | -78.64 | -141.76 | -95.58 | -- | -- | -- | -- | -- | -- | 0.049 | -- | -- | -- | 3.22 | -- | -- | -- |
| 2cureX AB | 13.24k | -2.63m | 685.73k | -- | -- | 0.5863 | -- | 51.79 | -1.75 | -1.75 | 0.0088 | 0.7777 | 0.0048 | -- | 0.0838 | -- | -95.89 | -38.21 | -108.66 | -43.48 | -6,889.68 | -22,153.06 | -19,883.23 | -38,685.30 | -- | -46.08 | -- | -- | 72.22 | -- | -3.52 | -- | -- | -- |
| Ovoca Bio PLC | 0.00 | -2.33m | 716.39k | 5.00 | -- | 0.1417 | -- | -- | -0.0245 | -0.0245 | 0.00 | 0.053 | 0.00 | -- | -- | 0.00 | -27.00 | -17.82 | -32.86 | -19.39 | -- | -- | -- | -- | 4.68 | -48.64 | 0.00 | -- | -- | -- | -6.96 | -- | -- | -- |
| Obseva SA | 13.81m | 7.39m | 735.46k | 15.00 | 0.1053 | 0.2625 | 0.0993 | 0.0533 | 0.0605 | 0.0605 | 0.1287 | 0.0243 | 0.4682 | -- | 108.39 | 902,889.60 | 25.07 | -73.61 | 37.56 | -90.70 | -- | -- | 53.55 | -838.80 | -- | -- | 0.1957 | -- | -11.55 | 314.75 | 43.60 | -- | -- | -- |
| Voyager Life PLC | 367.24k | -1.29m | 736.96k | 28.00 | -- | 0.9933 | -- | 2.01 | -0.0912 | -0.0912 | 0.0253 | 0.044 | 0.1897 | 1.58 | 3.85 | 11,214.29 | -66.51 | -- | -77.02 | -- | 41.72 | -- | -350.64 | -- | 2.83 | -69.50 | 0.4625 | -- | 59.55 | -- | -38.70 | -- | -- | -- |
| Oxurion NV | 263.00k | -18.97m | 901.48k | 20.00 | -- | -- | -- | 3.43 | -0.023 | -0.023 | 0.0002 | -0.0038 | 0.0284 | 63.60 | 0.1253 | 13,150.00 | -204.59 | -84.30 | -- | -118.70 | 39.54 | 48.90 | -7,212.55 | -2,008.99 | 0.1398 | -1.75 | -- | -- | -55.80 | -45.20 | 40.13 | -- | -65.17 | -- |
Data as of Apr 26 2024. Currency figures normalised to CoDon AG's reporting currency: Euro EUR
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Aramea Asset Management AGas of 30 Jun 2022 | 0.00 | 0.00% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
